Skip to main content
SpringerLink
Log in

High-dose praziquantel therapy for cerebral sparganosis

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Deng L, Xiong P, Qian S (2011) Diagnosis and stereotactic aspiration treatment of cerebral sparganosis: summary of 11 cases. J Neurosurg 114(5):1421–1425

    PubMed  Google Scholar 

  2. Kim DG, Paek SH, Chang KH, Wang KC, Jung HW, Kim HJ, Chi JG, Choi KS, Han DH (1996) Cerebral sparganosis: clinical manifestations, treatment, and outcome. J Neurosurg 85(6):1066–1071

    Article  PubMed  CAS  Google Scholar 

  3. Torres JR, Noya OO, Noya BA, Mouliniere R, Martinez E (1981) Treatment of proliferative sparganosis with mebendazole and praziquantel. Trans R Soc Trop Med Hyg 75(6):846–847

    Article  PubMed  CAS  Google Scholar 

  4. Sotelo J, Jung H (1998) Pharmacokinetic optimisation of the treatment of neurocysticercosis. Clin Pharmacokinet 34(6):503–515

    Article  PubMed  CAS  Google Scholar 

  5. Kong Y, Kang SY, Cho SY (1991) Single step purification of potent antigenic protein from sparganum by gelatin-affinity chromatography. Kisaengchunghak Chapchi 29(1):1–7

    PubMed  CAS  Google Scholar 

  6. Song T, Wang WS, Zhou BR, Mai WW, Li ZZ, Guo HC, Zhou F (2007) CT and MR characteristics of cerebral sparganosis. AJNR Am J Neuroradiol 28(9):1700–1705

    Article  PubMed  CAS  Google Scholar 

  7. Chang KH, Chi JG, Cho SY, Han MH, Han DH, Han MC (1992) Cerebral sparganosis: analysis of 34 cases with emphasis on CT features. Neuroradiology 34(1):1–8

    Article  PubMed  CAS  Google Scholar 

Download references

Conflicts of interest

On behalf of all authors, the corresponding author declares no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland

    Roman R. Gonzenbach, Michael Weller & Alexander Semmler

  2. Department of Molecular Parasitology, School of Medicine, Sungkyunkwan University, Seoul, Korea

    Yoon Kong

  3. Department of Infectiology, University Hospital, Zurich, Zürich, Switzerland

    Bernhard Beck

  4. Department of Radiology, University Hospital, Zurich, Zürich, Switzerland

    Alfred Buck

Authors
  1. Roman R. Gonzenbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoon Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernhard Beck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alfred Buck
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Weller
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alexander Semmler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roman R. Gonzenbach.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gonzenbach, R.R., Kong, Y., Beck, B. et al. High-dose praziquantel therapy for cerebral sparganosis. J Neurol 260, 1423–1425 (2013). https://doi.org/10.1007/s00415-013-6901-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-013-6901-7

Keywords

Search

Navigation